B
AMGN icon

Bellecapital’s Amgen AMGN Stock Holding History

Bellecapital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,107
Closed -$549K – 140
2024
Q4 		$549K Sell
2,107
-132
-6% -$39.2K 0.1% 81
2024
Q3 		$721K Sell
2,239
-891
-28% -$291K 0.14% 72
2024
Q2 		$978K Hold
3,130
– – 0.21% 70
2024
Q1 		$890K Sell
3,130
-89
-3% -$26K 0.2% 73
2023
Q4 		$927K Sell
3,219
-118
-4% -$32.2K 0.21% 69
2023
Q3 		$897K Buy
3,337
+6
+0.2% +$1.5K 0.22% 70
2023
Q2 		$740K Hold
3,331
– – 0.18% 87
2023
Q1 		$805K Buy
3,331
+292
+10% +$71.7K 0.2% 85
2022
Q4 		$798K Hold
3,039
– – 0.22% 82
2022
Q3 		$685K Buy
3,039
+40
+1% +$9.7K 0.21% 81
2022
Q2 		$730K Buy
2,999
+2
+0.1% +$490 0.2% 83
2022
Q1 		$725K Buy
2,997
+112
+4% +$25.7K 0.23% 81
2021
Q4 		$649K Sell
2,885
-28
-1% -$5.91K 0.18% 93
2021
Q3 		$619K Buy
2,913
+130
+5% +$29.9K 0.19% 97
2021
Q2 		$678K Sell
2,783
-112
-4% -$27.6K 0.21% 91
2021
Q1 		$720K Buy
2,895
+40
+1% +$9.54K 0.22% 81
2020
Q4 		$656K Buy
2,855
+179
+7% +$41.3K 0.22% 82
2020
Q3 		$680K Buy
2,676
+120
+5% +$29.7K 0.31% 62
2020
Q2 		$603K Hold
2,556
– – 0.28% 70
2020
Q1 		$518K Buy
2,556
+156
+7% +$34.1K 0.33% 66
2019
Q4 		$579K Buy
2,400
+235
+11% +$51.8K 0.3% 75
2019
Q3 		$419K Buy
2,165
+836
+63% +$160K 0.25% 81
2019
Q2 		$245K Buy
1,329
+80
+6% +$14.3K 0.15% 106
2019
Q1 		$237K Buy
+1,249
New +$239K 0.15% 102
2016
Q1 		– Sell
-1,600
Closed -$260K – 52
2015
Q4 		$260K Hold
1,600
– – 0.33% 44
2015
Q3 		$221K Hold
1,600
– – 0.33% 42
2015
Q2 		$246K Buy
+1,600
New +$256K 0.32% 44

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Bellecapital's AMGN Position: Q1 2025 in Review

Bellecapital sold out of Amgen (AMGN) in Q1 2025, closing a stake of 2,107 shares — an estimated $549K sold.

Bellecapital first reported a position in AMGN in Q2 2015 and held it in 27 quarters. The position peaked at $978K in Q2 2024. 2,933 funds tracked by Wall St. Rank hold AMGN as of Q1 2025.

  • Bellecapital reported no remaining Amgen position as of Q1 2025 after selling out during the quarter.
  • Bellecapital sold 2,107 Amgen shares in Q1 2025, an estimated $549K.
  • Bellecapital first reported a position in Amgen in Q2 2015 and held it in 27 quarters.
  • Bellecapital's Amgen position peaked at $978K in Q2 2024.
  • 2,933 funds tracked by Wall St. Rank held Amgen as of Q1 2025.

Based on Bellecapital's 13F filing for Q1 2025, filed 16 Apr 2025.